Medpace (MEDP) is Initiated by Wells Fargo to Outperform

Medpace (MEDP) was Initiated by Wells Fargo to “Outperform”. Wells Fargo advised their investors in a research report released on Sep 6, 2016.

Many Wall Street Analysts have commented on Medpace. Robert W. Baird Initiated Medpace on Sep 6, 2016 to “Neutral”, Price Target of the shares are set at $35.Medpace was Initiated by Jefferies to “Hold” on Sep 6, 2016.

In a different news, on Aug 19, 2016, August J. Troendle (CEO) purchased 10,000 shares at $27.98 per share price. According to the SEC, on Aug 18, 2016, Susan E Burwig (Sr. Vice President, Operations) purchased 19,211 shares at $29.25 per share price.


Leave a Reply

Medpace - Is it time to Sell?

Top Brokerage Firms are advising their investors on Medpace. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.